8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer)
Published . Updated .
Key takeaways
- 8-K - Mirum Pharmaceuticals filed an 8-K with the SEC on Oct 26 (a notice of a material company event).
- Exposed: MIRM
- Market reaction: MIRM +1.8% after three sessions
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Mirum Pharmaceuticals filed an 8-K with the SEC on Oct 26 (a notice of a material company event).
Directly affected
- MIRM Mirum Pharmaceuticals
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| MIRM | +1.94% | -0.58% | base | +2.51% | +2.79% | +3.52% | +1.77% |
| XLV | +0.28% | +1.14% | base | -0.06% | +0.27% | +2.66% | +3.13% |
| XBI | +1.83% | +0.75% | base | +2.88% | +4.65% | +4.85% | +3.62% |
| LLY | +0.43% | +2.14% | base | +0.16% | +0.88% | +7.35% | +10.75% |
| JNJ | -2.60% | +0.52% | base | +0.90% | +1.86% | +3.31% | +2.59% |
| PFE | +1.17% | +2.11% | base | +0.00% | -1.04% | +0.54% | +2.38% |
| MRK | +5.40% | +4.65% | base | +0.85% | +0.31% | +4.03% | +6.32% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-10-26 AccNo: 0001759425-26-000054 Size: 157 KB Item 8.01: Other Events
Source: sec-edgar
Mirum Pharmaceuticals (MIRM) since “8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer),” compared with the market
Since the first closing price after “8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer),” Mirum Pharmaceuticals (MIRM) is +9.05%.
| Company | When | Move | Status |
|---|---|---|---|
| JNJ | that day | +0.90% | final price |
| JNJ | the next day | +1.86% | final price |
| JNJ | two days later | +3.31% | final price |
| JNJ | three days later | +2.59% | final price |
| JNJ | three days earlier | +0.52% | final price |
| JNJ | five days earlier | -2.60% | final price |
| LLY | that day | +0.16% | final price |
| LLY | the next day | +0.88% | final price |
| LLY | two days later | +7.35% | final price |
| LLY | three days later | +10.75% | final price |
| LLY | three days earlier | +2.14% | final price |
| LLY | five days earlier | +0.43% | final price |
| Mirum Pharmaceuticals (MIRM) | that day | +2.51% | final price |
| Mirum Pharmaceuticals (MIRM) | the next day | +2.79% | final price |
| Mirum Pharmaceuticals (MIRM) | two days later | +3.52% | final price |
| Mirum Pharmaceuticals (MIRM) | three days later | +1.77% | final price |
| Mirum Pharmaceuticals (MIRM) | three days earlier | -0.58% | final price |
| Mirum Pharmaceuticals (MIRM) | five days earlier | +1.94% | final price |
| MRK | that day | +0.85% | final price |
| MRK | the next day | +0.31% | final price |
| MRK | two days later | +4.03% | final price |
| MRK | three days later | +6.32% | final price |
| MRK | three days earlier | +4.65% | final price |
| MRK | five days earlier | +5.40% | final price |
| PFE | that day | 0.00% | final price |
| PFE | the next day | -1.04% | final price |
| PFE | two days later | +0.54% | final price |
| PFE | three days later | +2.38% | final price |
| PFE | three days earlier | +2.11% | final price |
| PFE | five days earlier | +1.17% | final price |
| XBI | that day | +2.88% | final price |
| XBI | the next day | +4.65% | final price |
| XBI | two days later | +4.85% | final price |
| XBI | three days later | +3.62% | final price |
| XBI | three days earlier | +0.75% | final price |
| XBI | five days earlier | +1.83% | final price |
| XLV | that day | -0.06% | final price |
| XLV | the next day | +0.27% | final price |
| XLV | two days later | +2.66% | final price |
| XLV | three days later | +3.13% | final price |
| XLV | three days earlier | +1.14% | final price |
| XLV | five days earlier | +0.28% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 6 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 52 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 19 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 26 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 31 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 52 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 66 days before publication. Filed 8 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 31 Jul 2026. That is 87 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 32 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 68 days before publication. Filed 9 Sep 2026. View the filing.
- Donald J Trump, an executive branch official, sold Merck (MRK), worth $250,001 - $500,000 on 31 Jul 2026. That is 87 days before publication. Filed 22 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Mirum Pharmaceuticals (MIRM)
Companies tied to this story
- MIRM Mirum Pharmaceuticals
For “8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer),” Mirum Pharmaceuticals (MIRM) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> MIRM
How “8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer)” reaches Mirum Pharmaceuticals (MIRM)
“8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer)” (26 Oct 2026) reaches Mirum Pharmaceuticals (MIRM) through this story.
What ties Mirum Pharmaceuticals (MIRM) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> MIRM
Dates and price levels for Mirum Pharmaceuticals (MIRM)
MIRM traded between 79.72 and 98.73 across 20 sessions. The latest close on file is 93.29.
How solid “8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer)” looks
14 out of 100
“8-K - Mirum Pharmaceuticals, Inc. (0001759425) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.